Management

Following new data from Imperial College London (ICL) suggesting that antibody levels against SARS-CoV-2 wane over time; Michael…

while the coronavirus pandemic has lifted CSL Ltd's investment profile, virus anxieties are also hitting its most lucrative…

S Swaminathan, COO, GS1 explains how adoption of global standards can bring enhanced efficiencies in the supply chain and benefit…

Richa Mahindru, Domain Leader, Pharma and Life Sciences Practice, and Ishani Jain, Member, Pharma and Life Sciences Practice…

Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals highlights that the COVID-19 crisis has opened a window of opportunity…

Industry stakeholders share their views and concerns about the challenges and impact of the coronavirus pandemic and the…

Ravi Mathur, CEO, GS1 India talks about GS1’s initiatives for the pharma sector and the impact its aims to create, in an exclusive…

Express Pharma series on the key pillars of a strategic framework to tackle zoonotic diseases

Dealing with hampered production and lack of input raw materials, AGI glaspac has put in measures to cushion the blow. For…

Reji K Joseph, Associate Professor at Institute for Studies in Industrial Development, New Delhi writes about how different bodies…